Agenus | AGEN - 負債





負債 変化する 日付
AbbVie USD 72.86B 5.36B 2026-03
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 57.32B 2.72B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Celldex Therapeutics USD 1.91M 428K 2026-03
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 43.37B 867M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Intrexon USD 0 13.82M 2024-06
J&J USD 54.99B 7.05B 2026-03
Jiangsu Hengrui CNY 74.23M 17.2M 2025-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 36.51M 500K 2026-03
Merck EUR 12.04B 86M 2026-03
Merck USD 49.12B 222M 2026-03
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.19B 536M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 39.33M 321K 2026-03